Clinical Trials Logo

Renal Neoplasm clinical trials

View clinical trials related to Renal Neoplasm.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04933604 Completed - Surgery Clinical Trials

LPN in Patients With High-complex Renal Tumors

Start date: September 1, 2019
Phase:
Study type: Observational

The study aims to investigate the rationale for LPN in patients with high-complexity renal tumors in terms of oncologic and functional outcomes.

NCT ID: NCT04213157 Completed - Surgery Clinical Trials

Laparoscopic Partial Nephrectomy for cT1 Tumors

Start date: March 15, 2019
Phase:
Study type: Observational

The aim of the study is to evaluate trifecta and pentafecta outcomes for laparoscopic partial nephrectomy (LNP) in patients with clinical T1N0M0 renal tumor.

NCT ID: NCT03273751 Completed - Renal Injury Clinical Trials

The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study is intended to evaluate the renal protective effect of Remote Ischemic Preconditioning (RIPC) in patients undergoing partial nephrectomy. Half of the enrolled subjects will receive 4 cycles of brief ischemia on the upper arm after anesthesia induction and prior to the surgery, while the other half will not receive this treatment as a control group.

NCT ID: NCT02909452 Completed - Neoplasms Clinical Trials

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Start date: September 20, 2016
Phase: Phase 1
Study type: Interventional

The objectives of this study are to explore different dosing levels and schedules of entinostat in combination with pembrolizumab in patients with advanced solid tumors, in terms of safety, tolerability, pharmacokinetics (PK), impact on immune correlatives, and efficacy

NCT ID: NCT02897778 Completed - Neoplasms Clinical Trials

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Start date: August 24, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of entinostat on heart rate and other electrocardiogram (ECG) parameters. This study will also evaluate the safety and tolerability of entinostat, as well as pharmacokinetic and pharmacodynamic parameters.

NCT ID: NCT00034281 Completed - Breast Neoplasm Clinical Trials

Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

Start date: June 2002
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate a safe dose of TAK-165, once daily (QD), in patients with HER2-tumor expression.